Trials / Not Yet Recruiting
Not Yet RecruitingNCT05815810
Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.
Detailed description
The ultimate objective of this study is to use Community-Based Participatory Research (CBPR) methods to develop an effective user-friendly, health literate, inclusive and accessible mobile application (app) to improve access to gender affirming voice modification training for transgender and gender diverse (TGGD) individuals. The immediate objectives are to understand the needs of TGGD individuals in voice care,and identify barriers to creating a pilot app with evidence-based educational content for VCMT and to evaluate subjective and objective voice outcomes of TGGD participants with app use compared to standard behavioral intervention with a speech pathologist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Attuned: A mobile application | Subjects will undergo voice and communication modification therapy via the Attuned application. This consists of an 11 week program consisting of different modules to learn how to modify voice (e.g., pitch, intonation, resonance). At the end of each module, participants will be given exercises to practice what they learned. |
| OTHER | In-Person Voice Modification Therapy | Subjects will undergo standard of care in-person voice modification therapy at Ithaca College. |
Timeline
- Start date
- 2026-12-01
- Primary completion
- 2027-12-01
- Completion
- 2028-12-01
- First posted
- 2023-04-18
- Last updated
- 2025-12-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05815810. Inclusion in this directory is not an endorsement.